Trends & Insights, January 2026: A pharmaphorum industry report
Outside of what we’ve been reporting on in terms of news and in-depth features, interviews, and in-person event coverage, behind the headlines the year also opened with a flurry of regulatory milestones, ophthalmology advances, AI-first R&D announcements, and tangible investments in manufacturing and packaging capacity. Amid this, oncology continued to dominate outcomes news, but two…